Methods for treating delirium using glucocorticoid receptor-specific antagonists

Details for Australian Patent Application No. 2006233254 (hide)

International Classifications

Event Publications

16 November 2006 Complete Application Filed

23 November 2006 Application Open to Public Inspection

Published as AU-B-2006233254

2 August 2007 Application Accepted

Published as AU-B-2006233254

29 November 2007 Standard Patent Sealed

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

29 September 2011 Section 223 Application Received

Corcept Therapeutics, Inc. An application to extend the time from 06 May 2009 to 06 Sep 2011 in which to pay a renewal fee has been filed . Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000 2009

17 November 2011 Section 223 Application Allowed

Corcept Therapeutics, Inc. The time in which to pay a renewal fee has been extended to 06 Sep 2011. Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000 Extensions of Time, Section 223

24 November 2011 Corrigenda

Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2006 Delete all reference to Application No. 2006233254.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.